Evidence guide

Is remote patient monitoring cost-effective, and for whom?

Often, yes, but the answer depends on the condition and the program. Economic evaluations of hypertension RPM generally favored monitoring, and a hypertension program at NYU Langone Health reported a positive average return for the provider. This guide separates practice ROI, payer spending and cost-effectiveness so you can test the assumptions that drive each result for a combined RPM+CCM service.

Summary by Vironix Health · Source review: November 12, 2026
How we select and interpret evidence

Curation cutoff: November 12, 2026

What to take away

  • Economic evaluations of hypertension RPM generally favored monitoring; heart-failure and COPD results varied by setting and severity.
  • A published hypertension RPM program reported a positive average provider return; its sensitivity analysis shows which assumptions drive the result.
  • Practice ROI, payer savings and cost-effectiveness are different questions; cost a combined RPM+CCM service as one program, including what the service fee already covers.

Three financial questions that need different evidence

Question

What to measure

Evidence boundary

Is this financially sustainable for our practice?

Collected program revenue, agreed service fees and costs borne directly by the practice.

The Zhang analysis concerns one provider program; its sensitivity analysis includes losses.

Does it reduce payer spending?

Total spending compared with an alternative, including program payments.

The CMS CCM report separates gross and net estimates; its spending result changes under sensitivity analyses.

Do health gains justify the additional cost?

Incremental costs and health outcomes over a stated horizon.

The De Guzman review found variation by condition and setting, not one transferable RPM return.

Supporting studies: Donglan S Zhang (2026) [1]; John Schurrer (2017) [2]; Keshia R De Guzman (2022) [3]

Start with the economic perspective

De Guzman’s review found variation across conditions and settings. Gavan’s review addresses patient-reported mobile monitoring and excludes measurements requiring additional devices, such as BP cuffs or spirometers, as well as passive wearable monitoring. A symptom-monitoring economic model is not direct evidence for the margin of a connected BP-cuff service.

Supporting studies: Keshia R De Guzman (2022) [3]; Sean P Gavan (2025) [4]

Cost the combined pathway as one program

For a proposed RPM+CCM service, identify which activities are included: monitoring, outreach, adherence support, care-plan follow-up, coordination and clinical review. Match the costs to the agreed scope and avoid double-counting shared work already included in the service fee. This is a planning interpretation, not a return estimated by the studies.

Zhang’s RPM analysis and the CMS CCM evaluation concern different programs and economic perspectives; their results cannot be added to estimate a combined-program return.

Supporting studies: Donglan S Zhang (2026) [1]; John Schurrer (2017) [2]

Separate practice margin from patient benefit

Zhang’s final journal article evaluates a provider program’s costs and estimated reimbursement. Its sensitivity analysis includes losses. We use the journal abstract only and omit financial magnitudes whose time horizon could not be verified there; the earlier preprint is not counted separately.

Supporting studies: Donglan S Zhang (2026) [1]

Account for fees and uncertain denominators

The CMS report separates gross and net savings, with important sensitivity to analysis choices. Clark’s practice study has unresolved cost-unit and cohort inconsistencies. Neither justifies inserting a generic savings percentage into a local business case.

Supporting studies: John Schurrer (2017) [2]; Bennett W. Clark (2026) [5]

Virtual visits change different people’s costs

Lavin’s pandemic review reports heterogeneous findings across patient, payer and health-sector perspectives. Lower patient costs can coexist with higher telehealth spending and little change in total spending. Caffery found only a small economic evidence base comparing video with telephone. These results do not provide a transferable RPM ROI estimate.

Supporting studies: Lauren Lavin (2025) [6]; Liam J Caffery (2025) [7]

Evidence gaps

Economic studies use different comparators, costing methods and time horizons. Historical reimbursement assumptions are not current payment advice. The selected sources cannot provide a universal break-even enrollment target or a guaranteed return.

Practical interpretation

Interpret a study’s costs in the context of its delivery model. An internally staffed program may pay separately for devices, review, outreach and administration. A managed service may include those activities within its fee. Compare the service scope, implementation terms and any work handled directly by the practice; avoid counting the provider’s internal costs again when they are already included in the fee.

Use the proposed agreement and practice-specific assumptions to evaluate revenue, participation and collections. Review patient outcomes and experience alongside the financial result. Published economic studies provide context; they do not determine a particular service’s pricing, invoicing schedule or staffing arrangement.

The workflow guide explains coordination with a managed team. See Vironix RPM services to discuss the delivery model and commercial arrangements for your practice.

References

  1. Program cost and return on investment analysis of remote patient monitoring for hypertension management in the cardiology department of a large healthcare system

    Donglan S Zhang; Laure Millet; Brandon K Bellows; Sarah Lee; Devin Mann. Journal of Telemedicine and Telecare. 2026.

    Original source
  2. Evaluation of the Diffusion and Impact of the Chronic Care Management (CCM) Services: Final Report

    John Schurrer; Ann O'Malley; Claire Wilson; Nancy McCall; Neetu Jain. Mathematica Policy Research report for CMS. 2017.

    Original source
  3. Economic Evaluations of Remote Patient Monitoring for Chronic Disease: A Systematic Review

    Keshia R De Guzman; Centaine L Snoswell; Monica L Taylor; Leonard C Gray; Liam J Caffery. Value in Health. 2022.

    Original source
  4. Active remote monitoring of long-term conditions with mobile devices: a systematic review of cost-effectiveness analyses

    Sean P Gavan; Katherine Payne; William G Dixon; Sabine N van der Veer; Alexander C T Tam; Nick Bansback. npj Digital Medicine. 2025.

    Original source
  5. Cost impact of chronic care management services in a large multi-specialty practice: A pragmatic outcomes study

    Bennett W. Clark; Jacob Webster; Souvik Chatterjee; Michael D. Finch. PLOS One. 2026.

    Original source
  6. The Effect of Telehealth on Cost of Health Care During the COVID-19 Pandemic: A Systematic Review

    Lauren Lavin; Heath Gibbs; J Priyanka Vakkalanka; Sara Ternes; Heather S Healy; Kimberly A S Merchant; Marcia M Ward; Nicholas M Mohr. Telemedicine and e-Health. 2025.

    Original source
  7. Telephone versus video consultations: A systematic review of comparative effectiveness studies and guidance for choosing the most appropriate modality

    Liam J Caffery; Soraia De Camargo Catapan; Monica L Taylor; Jaimon T Kelly; Helen M Haydon; Anthony C Smith; Centaine L Snoswell. Journal of Telemedicine and Telecare. 2025.

    Original source

Explore Vironix services: RPM · CCM